BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hochmeister S, Engel O, Adzemovic MZ, Pekar T, Kendlbacher P, Zeitelhofer M, Haindl M, Meisel A, Fazekas F, Seifert-Held T. Lipocalin-2 as an Infection-Related Biomarker to Predict Clinical Outcome in Ischemic Stroke. PLoS One 2016;11:e0154797. [PMID: 27152948 DOI: 10.1371/journal.pone.0154797] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Shen L, Zhou J, Guo M, Yang C, Xu Q, Lv Q, Yang S, Huang H. Serum lipocalin-2 concentrations and mortality of severe traumatic brain injury. Clinica Chimica Acta 2017;474:130-5. [DOI: 10.1016/j.cca.2017.09.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Guardado S, Ojeda-Juárez D, Kaul M, Nordgren TM. Comprehensive review of lipocalin 2-mediated effects in lung inflammation. Am J Physiol Lung Cell Mol Physiol 2021;321:L726-33. [PMID: 34468208 DOI: 10.1152/ajplung.00080.2021] [Reference Citation Analysis]
3 Chen H, Shang D, Wen Y, Liang C. Bone-Derived Modulators That Regulate Brain Function: Emerging Therapeutic Targets for Neurological Disorders. Front Cell Dev Biol 2021;9:683457. [PMID: 34179014 DOI: 10.3389/fcell.2021.683457] [Reference Citation Analysis]
4 Zhang Y, Wang Y, Wu W, Liu P, Sun S, Hong M, Yuan Y, Xia Q, Chen Z. Elevation of neutrophil carcinoembryonic antigen-related cell adhesion molecule 1 associated with multiple inflammatory mediators was related to different clinical stages in ischemic stroke patients. J Clin Lab Anal 2022;:e24526. [PMID: 35657334 DOI: 10.1002/jcla.24526] [Reference Citation Analysis]
5 Krishnan S, Lawrence CB. Old Dog New Tricks; Revisiting How Stroke Modulates the Systemic Immune Landscape. Front Neurol 2019;10:718. [PMID: 31312180 DOI: 10.3389/fneur.2019.00718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
6 Wang G, Weng YC, Chiang IC, Huang YT, Liao YC, Chen YC, Kao CY, Liu YL, Lee TH, Chou WH. Neutralization of Lipocalin-2 Diminishes Stroke-Reperfusion Injury. Int J Mol Sci 2020;21:E6253. [PMID: 32872405 DOI: 10.3390/ijms21176253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Yu F, Saand A, Xing C, Lee JW, Hsu L, Palmer OP, Jackson V, Tang L, Ning M, Du R, Kochanek PM, Lo EH, Chou SH. CSF lipocalin-2 increases early in subarachnoid hemorrhage are associated with neuroinflammation and unfavorable outcome. J Cereb Blood Flow Metab 2021;:271678X211012110. [PMID: 33951946 DOI: 10.1177/0271678X211012110] [Reference Citation Analysis]
8 Bhusal A, Lee WH, Suk K. Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond. Front Physiol 2021;12:638112. [PMID: 33613327 DOI: 10.3389/fphys.2021.638112] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yang K, Deng HB, Man AWC, Song E, Zhang J, Luo C, Cheung BMY, Yuen KY, Jensen PS, Irmukhamedov A, Elie AGIM, Vanhoutte PM, Xu A, De Mey JGR, Wang Y. Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment. ESC Heart Fail 2017;4:563-75. [PMID: 29154418 DOI: 10.1002/ehf2.12183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
10 Huţanu A, Iancu M, Bălaşa R, Maier S, Dobreanu M. Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-Dimers, NGAL and NSE measured using a biochip array. Acta Pharmacol Sin 2018;39:1228-36. [PMID: 29926842 DOI: 10.1038/aps.2018.26] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
11 Moschen AR, Adolph TE, Gerner RR, Wieser V, Tilg H. Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation. Trends Endocrinol Metab. 2017;28:388-397. [PMID: 28214071 DOI: 10.1016/j.tem.2017.01.003] [Cited by in Crossref: 108] [Cited by in F6Publishing: 108] [Article Influence: 21.6] [Reference Citation Analysis]
12 Deng Y, Chen D, Gao F, Lv H, Zhang G, Sun X, Liu L, Mo D, Ma N, Song L, Huo X, Yan T, Zhang J, Miao Z. Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2. J Biol Eng. 2019;13:71. [PMID: 31485266 DOI: 10.1186/s13036-019-0193-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
13 Ranjbar Taklimie F, Gasterich N, Scheld M, Weiskirchen R, Beyer C, Clarner T, Zendedel A. Hypoxia Induces Astrocyte-Derived Lipocalin-2 in Ischemic Stroke. Int J Mol Sci 2019;20:E1271. [PMID: 30871254 DOI: 10.3390/ijms20061271] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
14 Dekens DW, Eisel ULM, Gouweleeuw L, Schoemaker RG, De Deyn PP, Naudé PJW. Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases. Ageing Res Rev 2021;70:101414. [PMID: 34325073 DOI: 10.1016/j.arr.2021.101414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
15 Pinyopornpanish K, Chattipakorn N, Chattipakorn SC. Lipocalin‐2: Its perspectives in brain pathology and possible roles in cognition. J Neuroendocrinol 2019;31. [DOI: 10.1111/jne.12779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]